SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Related Keywords

United States ,Maxime Taquet ,Sally Robertson ,Pfizer ,International Classification Of Diseases ,University Of Oxford ,International Classification ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Anxiety ,Arrhythmia ,Coronavirus ,Hair ,Hair Loss ,Hypoxemia ,Immunization ,Influenza ,Joint Pain ,Oxygen ,Rain ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Sleep ,Yndrome ,Thromboembolism ,Vaccine ,Venous Thromboembolism ,